Tiagabine antinociception in rodents depends on GABA(B) receptor activation: Parallel antinociception testing and medial thalamus GABA microdialysis

European Journal of Pharmacology

Volumn 368, Issue 2-3, 1999, Pages 205-211

  Ipponi, Alessandra ^a   Lamberti, Claudia ^a   Medica, Antonio ^b   Bartolini, Alessandro ^a   Malmberg Aiello, Petra ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Stabilimento Chimico Farmaceutico M   (Italy)

Author keywords

Antinociception; GABA ( aminobutyric acid); GABA(B) receptor; Medial thalamus; Microdialysis; Tiagabine

Indexed keywords

3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; TIAGABINE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; MOUSE; NONHUMAN; PAIN; PAIN THRESHOLD; PRIORITY JOURNAL; THALAMUS;

ABDOMEN; ANIMALS; BACLOFEN; CONSTRICTION, PATHOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCAPE REACTION; EXTRACELLULAR SPACE; GABA AGONISTS; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; MALE; MICE; MICRODIALYSIS; NALOXONE; NARCOTIC ANTAGONISTS; NEUROTRANSMITTER UPTAKE INHIBITORS; NIPECOTIC ACIDS; NOCICEPTORS; ORGANOPHOSPHORUS COMPOUNDS; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PSYCHOMOTOR PERFORMANCE; RECEPTORS, GABA-B; THALAMUS;

EID: 0032978974     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00034-5     Document Type: Article

References (34)

1. Altaffer F.B., de Balbian Verster F., Hall S., Long C.J., D'Encarnacao P. A simple and inexpensive cannula technique for chemical stimulation of the brain. Physiol. Behav. 5:1970;119-121.
2. Bank R.A., Jansen E.J., Beekman B., te Koppele J.M. Amino acid analysis by reverse-phase high-performance liquid chromatography: Improved derivatization and detection conditions with 9-fluorenylmethyl chloroformate. Anal. Biochem. 240:1996;167-176.
3. Bartolini A., Bartolini R., Biscini A., Giotti A., Malmberg P. Investigations into baclofen analgesia: effect of naloxone, bicuculline, atropine and ergotamine. Br. J. Pharmacol. 72:1981;156P-157P.
4. Borden L.A., Murali Dhar T.G., Smith K.E., Weinshank R.L., Branchek T.A., Gluchowski C. Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1. Eur. J. Pharmacol. 269:1994;219-224.
5. Borden L.A., Smith K.E., Vaysse P.J., Gustafson E.L., Weinshank R.L., Branchek T.A. Re-evaluation of GABA transport in neuronal and glial cell culture: correlation of pharmacology and mRNA localization. Recept. Channels. 3:1995;129-146.
6. Braestrup C., Nielsen E.B., Sonnewald U., Knutsen L.J.S., Andersen K.E., Jansen J.A., Frederiksen K., Andersen P.H., Mortensen A., Suzdak P.D. (R)-N-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]nipecotic acid binds with high affinity to the brain γ-aminobutyric acid uptake carrier. J. Neurochem. 54:1990;639-647.
7. Buckett W.R. Irreversible inhibitors of GABA-transaminase induce antinociceptive effects and potentiate morphine. Neuropharmacology. 19:1980;715-722.
8. Craig A.D., Bushnell M.C., Zhang E.-T., Blomqvist A. A thalamic nucleus specific for pain and temperature sensation. Nature. 372:1994;770-773.
9. Fink-Jensen A., Suzdak P.D., Swedberg M.D.B., Judge M.E., Hansen L., Nielsen P.G. The γ-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats. Eur. J. Pharmacol. 220:1992;197-201.
10. Giardina W.J. Anticonvulsivant action of tiagabine, a new GABA-uptake inhibitor. J. Epilepsy. 7:1994;161-166.
11. Haley T.J., McCormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. Chemother. 12:1957;12-15.
12. Holland K.D., McKeon A.C., Canney D.J., Covey D.F., Ferrendelli J.A. Relative anticonvulsivant effects of GABAmimetic and GABA modulatory agents. Epilepsia. 33:1992;981-986.
13. Kendall D.A., Browner M., Enna J. Comparison of the antinociceptive effect of γ-aminobutyric acid (GABA) agonists: evidence for a cholinergic involvement. J. Pharmacol. Exp. Ther. 220:1982;482-487.
14. Kisby G.E., Roy D.N., Spencer P.S. Determination of β-N-methylamino-L-alanine (BMAA) in plant (Cycas circinalis L.) and animal tissue by precolumn derivatization with 9-fluorenylmethyl chloroformate (FMOC) and reversed-phase high-performance liquid chromatography. J. Neurosci. Meth. 26:1988;45-54.
15. Koster R., Anderson M., De Beer E.J. Acetic acid for analgesic screening. Fed. Proc. 18:1959;412.
16. Lamberti C., Bartolini A., Ghelardini C., Malmberg-Aiello P. Investigation into the role of histamine receptors in rodent antinociception. Pharmacol. Biochem. Behav. 53:1996;567-574.
17. Leighton G.E., Rodriguez R.E., Hill R.G., Hughes J. κ-Opioid agonist produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat. Br. J. Pharmacol. 93:1988;553-560.
18. Löscher W., Schmidt D. Which animal model should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res. 2:1988;145-181.
19. B antagonist, prevents antinociception and muscle-relaxant effect induced by baclofen. Br. J. Pharmacol. 103:1991;1303-1308.
20. B receptors and antagonism by CGP35348, prevent bicuculline- and picrotoxin-induced antinociception. Neuropharmacology. 31:1992;783-791.
21. Malmberg-Aiello P., Lamberti C., Ghelardini C., Giotti A., Bartolini A. Role of histamine in rodent antinociception. Br. J. Pharmacol. 111:1994;1269-1279.
22. Mesdjian E., Defeudis S.V., Valli M., Jadot G., Mandel P. Antinociceptive action of sodium valproate in the mouse. Gen. Pharmacol. 6:1983;697-699.
23. Nielsen E.B., Suzdak P.D., Andersen K.E., Knutsen L.J.S., Sonnewald U., Braestrup C. Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor. Eur. J. Pharmacol. 196:1991;257-266.
24. O'Callaghan J.P., Holtzman S.G. Prenatal administration of morphine to the rat: tolerance to the analgesic effect of morphine in the offspring. J. Pharmacol. Exp. Ther. 197:1976;533-544.
25. B receptors. Eur. J. Pharmacol. 187:1990;27-38.
26. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic Press, London.
27. Richards D.A., Bowery N.G. Comparative effects of the GABA uptake inhibitors, tiagabine and NNC-711, on extracellular GABA levels in the rat ventrolateral thalamus. Neurochem. Res. 21:1996;135-140.
28. Roberts W.A., Eaton S.A., Salt T.E. Widely distributed GABA-mediated afferent inhibition processes within the ventrobasal thalamus of rat and their possible relevance to pathological pain states and somatotopic plasticity. Exp. Brain Res. 89:1992;363-372.
29. Sawynok J., LaBella F.S. On the involvement of GABA in the analgesia produced by baclofen, muscimol and morphine. Neuropharmacology. 21:1982;397-404.
30. Sherman S.E., Luo L., Dostrovsky J.O. Spinal strychnine alters response properties of nociceptive-specific neurons in rat medial thalamus. J. Neurophysiol. 78:1997;628-637.
31. Smith S.E., Parvez N.S., Chapman A.G., Meldrum B.S. The γ-aminibutyric acid uptake inhibitor, tiagabine is anticonvulsivant in two animal models of reflex epilepsy. Eur. J. Pharmacol. 273:1995;259-265.
32. Swedberg M.D.B. The mouse grid-shock analgesia test: pharmacological characterization of latency to vocalization threshold as an index of antinociception. J. Pharmacol. Exp. Ther. 269:1994;1021-1028.
33. Vaught J.L., Pelley K., Costa L.G., Setler P., Enna S.J. A comparison of the antinociceptive responses to the GABA-receptor agonist THIP and baclofen. Neuropharmacology. 24:1985;211-216.
34. Zorn S.H., Enna S.J. GABA uptake inhibitors produce a greater antinociceptive response in the mouse tail-immersion assay than other types of GABAergic drugs. Life Sci. 37:1985;1901-1912.